MEI Pharma, Inc. (MEIP)
NASDAQ: MEIP · Real-Time Price · USD
2.800
0.00 (0.00%)
Nov 21, 2024, 2:48 PM EST - Market open
MEI Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MEI Pharma stock has a target of 7.00, which predicts an increase of 150.00% from the current stock price of 2.80.
Analyst Consensus: Hold
* Price targets were last updated on Apr 12, 2024.
Analyst Ratings
The average analyst rating for MEI Pharma stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 23, 2024 |
| Stifel | Stifel | Hold Maintains $7 | Hold | Maintains | $7 | +150.00% | Apr 12, 2024 |
| Stifel | Stifel | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +150.00% | Feb 14, 2024 |
| Stifel | Stifel | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +221.43% | Sep 27, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +2,757.14% | May 23, 2023 |
Financial Forecast
Revenue This Year
6.38M
from 65.30M
Decreased by -90.24%
Revenue Next Year
25.50M
from 6.38M
Increased by 300.00%
EPS This Year
-5.80
from 2.67
EPS Next Year
-3.78
from -5.80
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 13.1M | 26.3M | 26.3M | |
| Avg | 6.4M | 25.5M | 25.5M | |
| Low | n/a | 24.5M | 24.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -79.9% | 311.8% | 2.9% | |
| Avg | -90.2% | 300.0% | - | |
| Low | - | 284.3% | -3.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -5.35 | -3.90 | -1.64 | |
| Avg | -5.80 | -3.78 | -1.59 | |
| Low | -6.15 | -3.64 | -1.53 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.